General Practice Research Database Seroquel XR Safety Study - GPRD SeroquelS
Study identifier:D1444C00006
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Epidemiology study to assess the safety of a new slow-release form of Seroquel (quetiapine) in the post-marketing phase in the UK
Medical condition
schizophrenia
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
37372
Study type
Observational
Age
18 Years - 85 Years
Date
Study Start Date: 01 Oct 2008
Primary Completion Date: 01 Dec 2012
Study Completion Date: 01 Dec 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
University Hospital Basel, Switzerland
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Quetiapine XR group | - |
| Non-quetiapine comparison group | - |
Contacts
Investigators
Principal Investigator
Christoph R Meier
University hospital of Basel, Switzerland
